Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1554

1.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Cheng W, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh SI; SYNERGY study investigators.

Lancet Neurol. 2019 Jul 5. pii: S1474-4422(19)30137-1. doi: 10.1016/S1474-4422(19)30137-1. [Epub ahead of print]

PMID:
31285147
2.

Epstein-Barr virus in pleural effusions: protagonist or pretender?

Arnold DT, Suri T, Hamilton F, Morley A, Medford A, Vipond IB, Muir P, Maskell NA.

Eur Respir J. 2019 Jun 27. pii: 1900825. doi: 10.1183/13993003.00825-2019. [Epub ahead of print] No abstract available.

PMID:
31248955
3.

A multicentre, phase 2a study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study.

Türeci O, Sahin U, Schulze-Bergkamen H, Zvirbule Z, Lordick F, Koeberle D, Thuss-Patience P, Ettrich T, Arnold D, Bassermann F, Al-Batran SE, Wiechen K, Dhaene K, Maurus D, Gold M, Huber C, Krivoshik A, Arozullah A, Park JW, Schuler M.

Ann Oncol. 2019 Jun 26. pii: mdz199. doi: 10.1093/annonc/mdz199. [Epub ahead of print]

PMID:
31240302
4.

White matter plasticity and maturation in human cognition.

Bells S, Lefebvre J, Longoni G, Narayanan S, Arnold DL, Yeh EA, Mabbott DJ.

Glia. 2019 Jun 24. doi: 10.1002/glia.23661. [Epub ahead of print] Review.

PMID:
31233643
5.

Maximising clinical benefit with adequate patient management beyond the second line in mCRC.

Argiles G, Arnold D, Prager G, Sobrero AF, Van Cutsem E.

ESMO Open. 2019 May 13;4(2):e000495. doi: 10.1136/esmoopen-2019-000495. eCollection 2019. Review.

6.

Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.

Maranzano J, Dadar M, Rudko DA, De Nigris D, Elliott C, Gati JS, Morrow SA, Menon RS, Collins DL, Arnold DL, Narayanan S.

AJNR Am J Neuroradiol. 2019 Jul;40(7):1162-1169. doi: 10.3174/ajnr.A6099. Epub 2019 Jun 20.

PMID:
31221631
7.

Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.

Arnold DG, Oakley JL.

J Health Polit Policy Law. 2019 Jun 7. pii: 7611647. doi: 10.1215/03616878-7611647. [Epub ahead of print]

PMID:
31199865
8.

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.

Marrie RA, O'Mahony J, Maxwell CJ, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

PLoS One. 2019 Jun 11;14(6):e0218215. doi: 10.1371/journal.pone.0218215. eCollection 2019.

9.

Imaging for malignant pleural effusions-still no routine role of positron emission tomography.

Arnold DT, Maskell N.

J Thorac Dis. 2019 Apr;11(4):1079-1081. doi: 10.21037/jtd.2019.02.99. No abstract available.

10.

First-Line Therapy for Immune Thrombocytopenia.

Mithoowani S, Arnold DM.

Hamostaseologie. 2019 Jun 6. doi: 10.1055/s-0039-1684031. [Epub ahead of print]

PMID:
31170773
11.

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL.

N Engl J Med. 2019 Jun 2. doi: 10.1056/NEJMoa1903387. [Epub ahead of print]

PMID:
31157963
12.

Sex-mismatched red blood cell transfusions and mortality: A systematic review and meta-analysis.

Zeller MP, Rochwerg B, Jamula E, Li N, Hillis C, Acker JP, Runciman RJR, Lane SJ, Ahmed N, Arnold DM, Heddle NM.

Vox Sang. 2019 Jul;114(5):505-516. doi: 10.1111/vox.12783. Epub 2019 May 23.

PMID:
31124172
13.

Accuracy of clinical coding of pleural empyema: A validation study.

Hamilton F, Arnold D.

J Eval Clin Pract. 2019 May 21. doi: 10.1111/jep.13184. [Epub ahead of print]

PMID:
31115122
14.

Neuromechanical Model of Rat Hindlimb Walking with Two-Layer CPGs.

Deng K, Szczecinski NS, Arnold D, Andrada E, Fischer MS, Quinn RD, Hunt AJ.

Biomimetics (Basel). 2019 Mar 1;4(1). pii: E21. doi: 10.3390/biomimetics4010021.

15.

Dose calculations in aircrafts after Fukushima nuclear power plant accident - Preliminary study for aviation operations.

Vargas A, Arnold D, Duch MA, Evangeliou N, Sievers K, Maurer C.

J Environ Radioact. 2019 Sep;205-206:24-33. doi: 10.1016/j.jenvrad.2019.04.013. Epub 2019 May 13.

16.

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.

Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group.

N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10.

PMID:
31075187
17.

Confidence as a diagnostic tool for perceptual aftereffects.

Gallagher RM, Suddendorf T, Arnold DH.

Sci Rep. 2019 May 9;9(1):7124. doi: 10.1038/s41598-019-43170-1.

18.

Magnetic field sensors using arrays of electrospun magnetoelectric Janus nanowires.

Bauer MJ, Wen X, Tiwari P, Arnold DP, Andrew JS.

Microsyst Nanoeng. 2018 Dec 3;4:37. doi: 10.1038/s41378-018-0038-x. eCollection 2018.

19.

Adverse events associated with weight-based, high-dose montelukast exposures in children.

Arnold DH, Bowman N, Reiss TF, Hartert TV, Akers WS, Seger DL.

Clin Toxicol (Phila). 2019 May 6:1-2. doi: 10.1080/15563650.2019.1609686. [Epub ahead of print] No abstract available.

PMID:
31056949
20.

Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.

Warkentin TE, Sheppard JI, Smith JW, Arnold DM, Nazy I.

Int J Lab Hematol. 2019 Aug;41(4):493-502. doi: 10.1111/ijlh.13031. Epub 2019 May 3.

PMID:
31050876
21.

Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment.

Cook SG, Goodell DJ, Restrepo S, Arnold DB, Bayer KU.

Cell Rep. 2019 Apr 16;27(3):658-665.e4. doi: 10.1016/j.celrep.2019.03.041.

22.

Complex oesophageal disease in a 72-year-old male.

McQuillan P, Cheah S, Arnold D, Wills V.

ANZ J Surg. 2019 Apr 11. doi: 10.1111/ans.15114. [Epub ahead of print] No abstract available.

PMID:
30974515
23.

Postnatal intervention for the treatment of FNAIT: a systematic review.

Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H; International Collaboration for Transfusion Medicine Guidelines (ICTMG).

J Perinatol. 2019 Apr 10. doi: 10.1038/s41372-019-0360-7. [Epub ahead of print] Review.

PMID:
30971767
24.

Hypopigmented Macules as Manifestation of Lichen Planus and Lichen Planopilaris.

Arnold D, Hoffman MB, Onajin O, Sangüeza OP, McMichael A.

Am J Dermatopathol. 2019 Jul;41(7):514-517. doi: 10.1097/DAD.0000000000001389.

PMID:
30946098
25.

The association between platelet transfusions and mortality in patients with critical illness.

Ning S, Liu Y, Barty R, Cook R, Rochwerg B, Iorio A, Warkentin TE, Heddle NM, Arnold DM.

Transfusion. 2019 Jun;59(6):1962-1970. doi: 10.1111/trf.15277. Epub 2019 Apr 1.

PMID:
30934133
26.

Prediction of acute asthma exacerbation severity and interrater reliability of manual pulsus paradoxus measurement.

Arnold DH, Vukovic AA, Arnold CG, Penrod C, Pologe JA.

Ann Allergy Asthma Immunol. 2019 Jun;122(6):653-654. doi: 10.1016/j.anai.2019.03.027. Epub 2019 Mar 28. No abstract available.

PMID:
30928416
27.

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.

Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ.

Neurology. 2019 Apr 9;92(15):e1724-e1738. doi: 10.1212/WNL.0000000000007262. Epub 2019 Mar 27.

28.

Suboptimal human multisensory cue combination.

Arnold DH, Petrie K, Murray C, Johnston A.

Sci Rep. 2019 Mar 26;9(1):5155. doi: 10.1038/s41598-018-37888-7.

29.

Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.

Diefenhardt M, Hofheinz RD, Martin D, Beißbarth T, Arnold D, Hartmann A, von der Grün J, Grützmann R, Liersch T, Ströbel P, Grabenbauer GG, Rieger M, Fietkau R, Graeven U, Weitz J, Folprecht G, Ghadimi M, Rödel F, Rödel C, Fokas E; German Rectal Cancer Study Group.

Int J Cancer. 2019 Mar 14. doi: 10.1002/ijc.32274. [Epub ahead of print]

PMID:
30868576
30.

Diagnostic Criteria for Symptomatic Neuroma.

Arnold DMJ, Wilkens SC, Coert JH, Chen NC, Ducic I, Eberlin KR.

Ann Plast Surg. 2019 Apr;82(4):420-427. doi: 10.1097/SAP.0000000000001796. Erratum in: Ann Plast Surg. 2019 Jul;83(1):120.

PMID:
30855369
31.

Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.

Wolfe AD, Arnold DB, Chen XS.

J Mol Biol. 2019 Mar 29;431(7):1506-1517. doi: 10.1016/j.jmb.2019.02.025. Epub 2019 Mar 4.

PMID:
30844405
32.

Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.

Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Kjaer M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia H, Landry D, Shehata N; International Collaboration for Transfusion Medicine Guidelines (ICTMG).

Br J Haematol. 2019 May;185(3):549-562. doi: 10.1111/bjh.15813. Epub 2019 Mar 3.

PMID:
30828796
33.

The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test.

Vrbensky JR, Moore JE, Arnold DM, Smith JW, Kelton JG, Nazy I.

J Thromb Haemost. 2019 May;17(5):787-794. doi: 10.1111/jth.14419. Epub 2019 Mar 20.

PMID:
30801909
34.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative.

Neurology. 2019 Mar 12;92(11):519-533. doi: 10.1212/WNL.0000000000007099. Epub 2019 Feb 20. Review. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30787160
35.

Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.

Bussel JB, Arnold DM, Boxer MA, Cooper N, Mayer J, Zayed H, Tong S, Duliege AM.

Am J Hematol. 2019 May;94(5):546-553. doi: 10.1002/ajh.25444. Epub 2019 Mar 13.

36.

Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.

Mexhitaj I, Nyirenda MH, Li R, O'Mahony J, Rezk A, Rozenberg A, Moore CS, Johnson T, Sadovnick D, Collins DL, Arnold DL, Gran B, Yeh EA, Marrie RA, Banwell B, Bar-Or A.

Brain. 2019 Mar 1;142(3):617-632. doi: 10.1093/brain/awz017.

PMID:
30759186
37.

A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis.

Fadda G, Brown RA, Magliozzi R, Aubert-Broche B, O'Mahony J, Shinohara RT, Banwell B, Marrie RA, Yeh EA, Collins DL, Arnold DL, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Ann Neurol. 2019 Mar;85(3):340-351. doi: 10.1002/ana.25429. Epub 2019 Feb 20.

38.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E.

Ann Oncol. 2019 May 1;30(5):871-873. doi: 10.1093/annonc/mdy510. No abstract available.

PMID:
30715202
39.

A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia.

Ivetic N, Arnold DM, Smith JW, Huynh A, Kelton JG, Nazy I.

Platelets. 2019 Jan 29:1-5. doi: 10.1080/09537104.2018.1562169. [Epub ahead of print]

PMID:
30693813
40.

Meta-analysis comparing outcomes of different transoral surgical modalities in management of oropharyngeal carcinoma.

Ibrahim AS, Civantos FJ, Leibowitz JM, Thomas GR, Arnold DJ, Franzmann EJ, Nicolli EA, Lo K, Nemeth Z, Sargi ZB, Weed DT.

Head Neck. 2019 Jun;41(6):1656-1666. doi: 10.1002/hed.25647. Epub 2019 Jan 28.

PMID:
30689251
41.

Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale.

Arnold DM, Jamula E, Heddle NM, Cook RJ, Hsia C, Sholzberg M, Lin Y, Kassis J, Blostein M, Larratt L, Amini S, Schipperus M, Carruthers J, Lane SJ, Li N, Kelton JG.

Thromb Haemost. 2019 Mar;119(3):500-507. doi: 10.1055/s-0038-1677531. Epub 2019 Jan 27.

PMID:
30685874
42.

Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.

Huynh A, Arnold DM, Kelton JG, Smith JW, Horsewood P, Clare R, Guarné A, Nazy I.

J Thromb Haemost. 2019 Feb;17(2):389-399. doi: 10.1111/jth.14369.

PMID:
30582672
43.

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL.

Mult Scler. 2018 Dec 19:1352458518814117. doi: 10.1177/1352458518814117. [Epub ahead of print]

PMID:
30566027
44.

Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.

Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J; International Collaboration for Transfusion Medicine Guidelines.

Vox Sang. 2019 Jan;114(1):79-94. doi: 10.1111/vox.12725. Epub 2018 Nov 22.

PMID:
30565711
45.

Using the emergency department to investigate smoking in young adults.

Kantrow SP, Jolley SE, Price-Haywood EG, Wang X, Tseng TS, Arnold D, Brown LF, Leonardi C, Scribner RA, Trapido EJ, Lin HY.

Ann Epidemiol. 2019 Feb;30:44-49.e1. doi: 10.1016/j.annepidem.2018.11.007. Epub 2018 Nov 24.

46.

How do we diagnose immune thrombocytopenia in 2018?

Kelton JG, Vrbensky JR, Arnold DM.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):561-567. doi: 10.1182/asheducation-2018.1.561. Review.

PMID:
30504358
47.

External validation of a clinical prediction rule for very low risk pediatric blunt abdominal trauma.

Springer E, Frazier SB, Arnold DH, Vukovic AA.

Am J Emerg Med. 2018 Nov 23. pii: S0735-6757(18)30943-4. doi: 10.1016/j.ajem.2018.11.031. [Epub ahead of print]

PMID:
30502218
48.

Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer.

Loupakis F, Hurwitz HI, Saltz L, Arnold D, Grothey A, Nguyen QL, Osborne S, Talbot J, Srock S, Lenz HJ.

Br J Cancer. 2018 Dec;119(12):1451-1455. doi: 10.1038/s41416-018-0304-6. Epub 2018 Nov 29.

49.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):19-33. doi: 10.1093/annonc/mdy502.

PMID:
30475956
50.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Lordick F, Tsushima T, Pentheroudakis G, Baba E, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Kato K, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Nakajima TE, Shitara K, Kawakami H, Narita Y, Yoshino T, Van Cutsem E, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):34-43. doi: 10.1093/annonc/mdy498.

PMID:
30475943

Supplemental Content

Loading ...
Support Center